Skip to content

Implementation of integrated clinical pathway in patients with non-surgical degenerative knee arthritis

Implementation of integrated clinical pathway in patients with non-surgical degenerative knee arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009057
Enrollment
58
Registered
2023-12-18
Start date
2023-12-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Test group: Integrated CP application group. According to the integrated CP, medical treatment is carried out once every two weeks, and Korean medicine treatment is carried out onc

Sponsors

Kyung Hee University Oriental Medicine Hospital at Gangdong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women over 40 years old but under 70 years old 2) Those with Kellgren-Lawrence grade 2 or 3 on knee joint radiography 3) Those diagnosed with knee osteoarthritis according to the ACR (American College of Rheumatology criteria) diagnostic criteria 4) Those who receive minimal help regarding their pain, are able to communicate sufficiently with the researcher, and are able to fill out the questionnaire. 5) Those who voluntarily agreed to participate in this clinical trial

Exclusion criteria

Exclusion criteria: 1) Patients with a history of knee joint trauma or surgery on the knee joint within 6 months from the time of screening 2) Patients who have received intra-articular injection treatment within 6 months from the time of screening (steroids, hyaluronic acid, etc.) 3) Patients who are suspected to have following diseases in physical examination and diagnostic examination: rheumatoid arthritis, autoimmune disease, septic arthritis, inflammatory joint disease, fibromyalgia 4) Patients receiving treatment for mental disorders such as depression and schizophrenia 5) Patients with other diseases that may interfere with treatment, such as serious gastrointestinal or cardiovascular diseases, uncontrolled hypertension or diabetes, serious kidney or liver diseases, or hemorrhagic diseases 6) Patients who have concomitant diseases which is prohibited to prescribe non-steroidal anti-inflammatory painkillers, hypersensitivity reactions to non-steroidal anti-inflammatory painkillers, and who have taken concomitant drugs. 7) Pregnant and lactating women 8) Participants whose participation in clinical research is determined to be difficult at the discretion of the research staff

Design outcomes

Primary

MeasureTime frame
Korean version of Western Ontario and McMaster Scale (KWOMAC)

Secondary

MeasureTime frame
100mm pain VAS;EQ-5D-5L;Treatment satisfaction evaluation;Employee satisfaction evaluation;Adverse event;Laboratory test;Vital sign;Change of the concomitant drug

Countries

Korea, Republic of

Contacts

Public ContactYeoncheol Park

Kyung Hee University Oriental Medicine Hospital at Gangdong

icarus08@hanmail.net+82-2-440-6275

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026